The Degree of Post-Mastectomy Upper Limb Lymphedema in Relation to the Extent of Axillary Lymph Nodes Involvement and Dissection Ahmed N Abdulnabi* CABS, Issam Merdan** FICMS CABS
Background: Lymphedema of the upper extremity is a serious consequence of breast cancer surgery. Postmastectomy lymphedema of the upper limb is usually related to many risk factors like axillary surgery, radiotherapy, venous obstruction, obesity, and infection.
Objectives: To identify the relationship between the extent of axillary lymph nodes involvement and dissection on the development of upper limb lymphedema.
Methods: One hundred and seventy patients managed by modified radical mastectomy with axillary dissection for mammary invasive adenocarcinoma between January 2009 and December 2016 in Al-Fayhaa Teaching Hospital. The patients were divided in to three groups according to the number of lymph nodes involvement by pathology. The patients had been followed up for a minimum of two years and assessed by standard lymphedema assessment, then categorized in to three groups according to the severity of lymphedema.
Results: After the analysis of patient parameters, the highest age group was 36-45 years. More than 60% of the patients had 4-9 lymph nodes involvement. Forty one patients from the 170 developed lymphedema postoperatively. Forty patients had seroma and twenty one patients had wound infection postoperatively.
Conclusion: Postmastectomy lymphedema is sequelae of disease process related to the extent of lymph nodes involvement and resection rather than operative fault.
Copyright (c) 2019 Iraqi Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Share — copy and redistribute the material in any medium or format
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.